NewsRx

Search our medical news database

Carl Zeiss

Ad-hoc: Carl Zeiss Meditec AG acquires ophthalmic surgery specialist Acri.Tec AG

Published in Lab Business Week, September 23rd, 2007

Carl Zeiss Meditec AG (ISIN: DE0005313704) intends to acquire Acri.Tec AG, based in Hennigsdorf. This is the object of a share purchase agreement that both sides signed this noon at around 11:45. Acri.Tec AG, which generated sales revenues in financial year 2006 in the amount of EUR 15.4 million, specialises in innovative implants (intraocular lenses) and other products for ophthalmic surgery (viscoelastic solutions and products for vitreoretinal surgery). The enterprise value calculated for Acri.Tec AG totals EUR 24 million and has to be reduced by the net financial debt at the closing date in order to determine the final purchase price. Carl Zeiss Meditec AG will acquire all shares of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook